Acyclovir elaidate

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAcyclovir elaidate
Drug Alias NameCP-4010P-4010
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA-directed DNA polymerase inhibitors
TargetsDNA-directed DNA polymerase
Therapy Area/IndicationsHerpesviridae Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNorsk Hydro
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAqualisNorsk Hydro
Active IndicationsN/A
Inactive IndicationsHerpesviridae Infections

Other Information

ATC CodeN/A
Related LinksN/A